LabCorp Test

STD #2 Essential Blood and Urine Test Panel, 9 Tests

Quick Overview

Chlamydia/Gonococcus Nucleic Acid Amplification (NAA), Rapid Plasma Reagin (RPR) Qualitative, Rapid, Hepatitis A Antibody IgM Blood Test, Hepatitis B Surface Antigen plus Human Immunodeficiency Virus 1 and 2 Test, Herpes Simplex Virus (HSV) Types 1 and 2 IgG, Hepatitis C Antibody.

Test #598


Availability: In stock

Preparation No fasting required. Patient should not urinate one hour prior to collection. Stop biotin consumption at least 72 hours prior to the collection.
Test Results 3-5 days. May take longer based on weather, holiday or lab delays.

The STD #2 Essential Blood and Urine Panel includes:

The most common bacterial sexually transmitted disease (STD) in the US, Chlamydia is more common among people 15-25 years of age. An estimated 3 million Americans or more are infected with Chlamydia each year. Many people do not experience any symptoms, so cases often go undiagnosed and unreported but over 1 million new cases are reported each year. Diagnosis and treatment of Chlamydia is very important to prevent long-term complications and spread of the infection to others. Chlamydia is usually transmitted through sexual contact (oral, vaginal, or anal) with an infected partner. Risk factors include having co-infection or previous infection with another STD, multiple sex partners, and not using barrier contraception consistently. An infected mother may spread the disease to her baby during childbirth. These infants are in danger of developing conjunctivitis, an inflammation that can threaten eyesight, and pneumonia.

Gonorrhea is an easily treated STD, but left untreated can cause severe reproductive and health problems.

RPR, Qualitative - tests for the bacterium that causes syphilis, Treponema pallidum. Syphilis is an infectious disease most often spread by sexual contact, including direct contact with a syphilis sore (chancre). Syphilis is easily treated but left untreated can cause severe health problems. Infected mothers can also pass the disease to the fetus, with serious and potentially fatal consequences for the baby.

Hepatitis A Antibody IgM Blood Test IgM anti-HAV antibodies indicate a recent infection with the hepatitis A virus. IgM anti-HAV antibodies can generally be detected in the blood as early as 2 weeks after the initial HAV infection. The antibodies will disappear from the blood 3 to 12 months after the infection. IgG anti-HAV antibodies indicate that you have had a hepatitis A viral infection. About 8 to 12 weeks after the initial infection with hepatitis A virus, IgG anti-HAV antibodies will appear and will remain in the blood for lifelong protection (immunity) against HAV.

Hepatitis B Surface Antigen (HBsAg) is a protein antigen that is produced by HBV. It is the earliest indicator of acute hepatitis B and often identifies infected people before symptoms appear. During the recovery period, HBsAg disappears from the blood. In certain people (particularly those infected as children or those with a weak immune system, such as those with AIDS), chronic infection with HBV may occur and HBsAg remains positive.

The HIV Antigen/Antibodies Test is the recommended standard rapid test for routine HIV Screening. It typically sees quick results in just 1-2 business days and is one of the most affordable HIV tests available. The HIV Antigen/Antibodies test, also known as a 4th Generation HIV Test, looks for both antibodies to the HIV virus and the p24 Antigen which is specific to HIV. Antibodies to HIV typically begin to develop several weeks after exposure. In the majority of people, these antibodies will be detectable by 12 weeks from the point of exposure. In some people, antibodies may be detectable as early as 4 weeks from exposure. The p24 Antigen is a viral protein which makes up the majority of the HIV viral core (capsid). P24 Antigen levels are typically highest a few weeks after exposure and drop to undetectable levels during the time when antibodies begin to develop. The combination of screening for both antibodies and antigen allow this test to detect a significantly higher number of early infections than previous generations of HIV screening.

Hepatitis C Antibody - Following the development of specific and sensitive testing for hepatitis B, 90% of post-transfusion hepatitis is now hepatitis C. A gene product (c100) of hepatitis C virus (HCV) was isolated and an assay for anti-HCV was then developed. The assay detects antibody to a presumptive flavivirus or togavirus which may be an etiologic agent of non-A, non-B hepatitis (which may not be a unitary disease entity).
Hepatitis C serology will correlate with surrogate tests for non-A, non-B hepatitis (ALT and anti-HBc) for blood donors. Since hepatitis C serology identifies a broader group of infected individuals than surrogate testing does, it reduces risk of HCV during transfusion. Studies conducted in hemophiliacs indicate that antibody to HCV is a reliable marker of HCV.

Herpes Simplex Virus (HSV) I and II.  Herpes simplex viruses which are more commonly known as herpes, are categorized into two types: herpes type 1 (HSV-1, or oral herpes) and herpes type 2 (HSV-2, or genital herpes). Herpes type 1 most commonly causes sores around the mouth and lips (sometimes called fever blisters or cold sores). HSV-1 may cause genital herpes, but most cases of genital herpes are caused by herpes type 2. In HSV-2, the infected person may have sores around the rectum or genitals. Although HSV-2 sores may occur in other locations, these sores generally are found below the waist.

Trusted, Secure, & Confidential

Please wait...